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Abstract
The mitochondrial genomic material (mtDNA), similarly to nuclear genome, is 
exposed to a plethora of exogenous and endogenous agents, as well as natural processes 
like replication that compromise the integrity and fidelity of the mtDNA, despite the 
abovementioned, the mtDNA does not contain genes involved in DNA repair, there-
fore mitochondria completely depend on the importation of nuclear-encoded elements 
to achieve genome maintenance, which implies a coordinated crosstalk between these 
two organelles. It has been determined that to counteract damage, mitochondria pos-
sess well-defined repair pathways quite similar to those of the nucleus, among which 
are: base excision repair (BER), mismatch repair (MMR), single-strand break repair 
(SSBR), microhomology-mediated end joining (MMEJ), and probably homology 
recombination dependent repair (HRR). If these repair pathways are nonfunctional 
and the lesions remain unrepaired, the emergence of mutations, deletions, and other 
insults may result in compromised cellular viability and disease.
Keywords: mitochondria, mtDNA, damage, repair, BER, MMR, SSBR,  
HRR, MMEJ
1. Introduction
The mitochondrion is an essential organelle involved principally in the produc-
tion of ATP and other metabolites which are important to several cellular functions, 
besides this organelle participates in other processes as iron-sulfur cluster biogen-
esis, heme production, and calcium regulation [1]. The mitochondrion possesses 
its own circular genomic material (mtDNA), which is exposed to the same DNA 
lesions as nuclear genome is, however, unlike the latter, mtDNA does not encode for 
genes involved in DNA maintenance or repair which implies that these processes 
completely depend on nuclear-encoded elements translocated to mitochondria. It 
was first thought that mitochondria lacked the ability to repair its DNA material, 
and this assumption was originated due to the observation of the absence of pyrimi-
dine dimer resolution after ultra violet light exposition in mammalian cells [2]; 
however, nowadays, the study of mtDNA repair pathways has evolved into a com-
plete research area that is constantly growing, since it has been observed that mito-
chondria not only possess some of the nuclear-conserved mechanisms like: base 
excision repair (BER), mismatch repair (MMR), single-strand break repair (SSBR), 
microhomology-mediated end joining (MMEJ), and homologous recombination 
DNA Repair - An Update
2
dependent repair (HRR), additionally mitochondria have evolved specific unique 
methods to deal with mtDNA insults based on the redundancy nature of mtDNA 
and mitochondrion itself, if the damage surpasses its repair capabilities, the mtDNA 
molecules can be destroyed and replicated again or even the whole organelle can 
be degraded [3]. Of importance, lesions that remain unrepaired in mtDNA such 
as deletions, mutations, inversions, and other rearrangements have been linked 
to several heritable disease syndromes [4]; further, mtDNA rearrangements and 
deletions have been associated with aging and cancer (www.mitomap.org/org/
MITOMAP) [5]. In this chapter, we will summarize the different mechanisms by 
which the mammalian mtDNA can be damaged and the described pathways that are 
involved in maintenance of fidelity and integrity of mitochondrial genome.
2. The mitochondrial genome
One of the features of mammalian cells is that they have two DNA-containing 
compartments: nuclei and mitochondria. Nuclear genome is large, diploid, and lin-
ear; in contrast, mitochondrial genome is polyploid and quite small, since is formed 
by a 16,569 pb circular molecule that accounts for 0.0005% of the human genome 
and 0.1% of the total number of genes in the human; mtDNA is redundant, since a 
few hundred to few thousand copies can be found per cell [3], when all the copies 
are identical, the genotype is termed homoplasmy, instead when multiple forms 
exist within the same tissue or cell; the genotype is called heteroplasmy [6]. The 
mitochondrial genome presents 37 genes, 13 of which encode for proteins oxidative 
phosphorylation chain specific and the remaining are implicated in translation: 2 
ribosomal RNAs (small of 12S and large of 16S) and 22 tRNAs. The grade of compac-
tion of mtDNA is interesting since it has no introns, and the intergenic regions are 
almost absent, additionally there are two noncoding regions: one of approximately 
1 kb known as noncoding region (NCR) and another small of 30 bp, both implicated 
in regulation of replication and transcription [7]. The NCR presents a triple stranded 
region, named D-loop, which occupies most of its extension and is related to the 
start of transcription [8], besides it has been observed that some genes overlap and 
others lack termination codons; therefore, it has been established that the promoters 
produce polycistronic transcripts which are further processed to generate mature 
RNA molecules [9]. As mentioned above, some of the proteins involved in respira-
tory system and ATP synthesis, which are extremely important to cellular functions, 
are encoded by mtDNA and not the nuclear genome, thus it is important to maintain 
mitochondrial genome integrity to preserve homeostasis [10].
Despite the advances made in the study of mtDNA replication mechanism, 
the exact machinery and steps involved in this procedure are not fully known; 
however, it has been determined a general head core to this process which con-
sists of the polymerase gamma (Polγ), a DNA helicase named Twinkle, and the 
mitochondrial single-stranded binding protein (mtSSB) [11]. Nowadays, there are 
three proposed models to explain mtDNA replication: (1) the first is quite similar 
to nucleus DNA replication, with standard leading and lagging strand replication, 
(2) a strand displacement model, where the lagging strand is synthetized once the 
leading has advanced and synthetized a long fragment, and (3) in this model, the 
lagging strand is hybridized with complementary RNA, a mechanism termed RNA 
incorporation throughout the lagging strand (RITOL) [8]. Another interesting 
feature about mtDNA replication is that contrary to what occurs in nuclear genome, 
mitochondrial genome replication is not limited to S phase of the cell cycle [12].
Unlike the nucleus, where the DNA forms part of nucleoprotein complexes, con-
sisting of DNA molecules wrapped around histone structures, the mitochondrial 
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genome does not present histones. It has been thought that this lack is responsible of 
the high rate of mtDNA mutagenesis, which is 10-fold greater than that in nucleus; 
however, this hypothesis is controversial since experimental evidence has suggested 
that histones might provoke DNA damage instead of preventing it [3]. Despite the 
above, mitochondrial genome is not naked; it is packaged into protein-DNA com-
plexes, which are termed mitochondrial nucleoids due to its similarity to bacterial 
chromosomes [13]. The most abundant nucleoid-associated proteins are mtSSB, 
transcription factor A of mitochondria (TFAM), Polγ, mitochondrial RNA poly-
merase (POLRMT), and Twinkle DNA helicase [14].
3. Sources of mtDNA damage
Mitochondrial genome is exposed to almost the same insults that nuclear 
genome is, which can be originated by internal and external sources. Six types of 
DNA damage have been proposed to be the more relevant in mitochondria [3].
3.1 Alkylation damage
This kind of lesion may be due to exposition to exogenous agents as chemothera-
peutic drugs, diet, and tobacco smoke; however, DNA alkylation damage can also 
be generated from the interaction of DNA with endogenous molecules [15], such as 
betaine, choline, and S-adenosylmethionine (SAM); the latter is the most relevant 
alkylating agent in the cell; SAM is a co-substrate involved in the transfer of methyl 
groups, when incubated with DNA in aqueous solutions leads to base modification, 
forming small amounts of 7-methylguanine and 3-methyladenine nonenzymati-
cally, therefore SAM acts as a weak DNA-alkylating agent [16]. Of interest, these 
DNA modifications, in specific 7-methylguanine can trigger the formation of 
mutagenic apurinic sites (AP) and imidazole ring opening which results in the stop-
page of replication machinery [17]; moreover, 3-methylguanine itself is a cytotoxic 
DNA lesion that also blocks replication [15]. Interestingly, mitochondria store about 
30% of total hepatic SAM [18], thus mtDNA is constantly exposed to this alkylating 
agent, which threats its stability and integrity.
3.2 Hydrolytic damage
There are two types of hydrolytic damage, the first is the formation of AP sites 
as a product of hydrolysis of the glycosidic bonds between bases and deoxyribose, 
and these lesions could appear due to heating, alkylation damage (previously 
mentioned) or by the action of N-glycosylases [19]. It has been estimated that AP is 
one of the most frequent lesions in the DNA, with approximately 10,000 lesions per 
cell, per day [20]. Interestingly, typical AP sites generate base pair modifications, 
since there is a preference to incorporate adenine opposite to AP by polymerases 
during DNA replication [21]. The other form of hydrolytic damage is the hydrolytic 
deamination of bases, where cytosine and its homolog 5-methylcitosine are mainly 
affected. It is noteworthy that the conversion of cytosine to uracil may introduce 
punctual mutations to the genome during replication if left unrepaired [20].
3.3 Formation of adducts
This type of lesions can be generated for exposition to ultraviolet type B and C 
light which produce bulky DNA adducts termed photodimers, in addition, activated 
metabolites of several organic contaminants, for example, polycyclic aromatic 
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hydrocarbons and mycotoxins may bring about adducts [1]. On the other hand, 
adduct formation can also be stimulated by endogenous factors, for example, it has 
been demonstrated that reactive intermediate products of diethylstilbestrol metab-
olization form DNA adducts preferentially with mitochondrial genome, where 
these insults are suggested to avoid replication and/or transcription, thus producing 
mtDNA instability in vivo [22].
3.4 Mismatches
During replication, polymerases can introduce base to base mismatches as well 
as generate nucleotide insertions or deletions in mitochondria, which are normally 
known as insertion-deletion loops (IDLs). One important source of mismatches are 
damaged deoxyribonucleotide triphosphates (dNTPs), predominantly oxidized, 
which can be incorporated to DNA during synthesis [3, 10].
3.5 DNA strand breaks
These injuries are divided based on the breaking of one or both strands. Single 
strand breaks (SSBs) can be generated by normal cellular procedures that went 
wrong, such as erroneous or abortive activity of DNA topoisomerase I (Top1), 
which presents mitochondrial localization, and when it fails may produce protein-
linked DNA breaks [23], also SSBs are produced by ineffective base excision repair 
(BER), or by oxidative stress [24]. One lesion related to SSBs is the formation of a 
covalently linked AMP to a 5′ phosphate, product of an unsuccessful DNA ligase 
activity [25]. On the other hand, double strand breaks (DSBs) are the most harm-
ful, since they can provoke global cellular responses that involve many aspects of 
cell metabolism [26]. These lesions may occur by endogenous agents like reactive 
oxygen species (ROS), errors in DNA metabolism by topoisomerases, and nucleases 
or detention of replisome. On the other hand, lesion can be caused by exogenous 
insults such as ionizing radiation and chemotherapeutic drugs [1].
3.6 Oxidative damage
In living organisms, ROS are normally produced as a consequence of endog-
enous metabolic reactions and also by external factors. ROS include superoxide 
anion (O2
−), hydrogen peroxide (H2O2), hydroxyl radical (OH
−), and single oxygen 
(O2), all of them can oxidize DNA molecules and generate several types of dam-
age including oxidized bases and single- and double-strand breaks [15]. Oxidative 
damage is by far the most prevalent and studied in mtDNA, since mitochondria are 
an important contributor in the creation of ROS [27], generated by the leakage of 
electrons from the electron transportation chain (ETC) [28], and there are at least 
nine sites responsible for generating the superoxide anion [29]. The importance of 
ROS affecting mtDNA lies in the observation that oxidative damage accumulates 
in several human diseases [30]. Of interest, it has also been reported that reactive 
nitrogen species (RNS) are able to oxidize or deaminate DNA and produce strand 
breaks, lesions that could be possible in mtDNA since these RNS can be found in 
mitochondria [31, 32].
4. Mitochondrial DNA repair machinery
Most of the repair pathways used by mitochondria to deal with its damaged 
DNA are quite similar to those operating in the nucleus; this observation makes 
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sense when we realize that mitochondrion relies completely in import of DNA 
repair elements encoded by nuclear genome, despite that mitochondrial genome 
does not contain any gene implicated in repair; it appears that the mitochondrial 
version of the repair machinery operates with fewer proteins than the nuclear 
counterparts [33] (Figure 1).
4.1 Base excision repair (BER)
Base excision repair (BER) is the commissioned pathway to removed nonbulky 
lesions like alkylated, deaminated, and oxidized bases from the DNA. This pathway 
has been well studied in the nucleus and was the first repair mechanism reported in 
mitochondria and to date the best characterized in this last organelle [33, 34]. BER 
mechanism is highly conserved from bacteria to humans and basically comprises five 
stages: (1) recognition and excision of the damaged base, (2) removal of the abasic site 
formed, (3) DNA end processing, (4) repair synthesis, and (5) ligation [35], and at the 
same time, BER can be divided into two branches (both founded in mitochondria): 
short patch and long patch, where the difference lies in the procedure used to repair, 
while short patch forms a single nucleotide gap, long patch forms a bigger one of 2–10 
nucleotides [36]. One of the main elements involved in BER processes are the DNA 
glycosylases, enzymes that catalyze the excision of the N-glycosidic bond between 
the altered base and its corresponding carbohydrate, thus creating an abasic site, and 
activity that was first observed by Lindahl et al. [37]. These glycosylases can be sub-
divided into monofunctional or bifunctional, depending on whether they have lyase 
activity or not, ability that determines the type of damage they can repair, while mono-
functional glycosylases focus on nonoxidative damage, bifunctional exert their action 
against oxidized DNA bases [35]. In mammalian mitochondria, seven glycosylases 
have been reported, three monofunctional: uracil-DNA glycosylase (UNG1), E. coli 
MutY homolog (MYH), and N-methylpurine DNA glycosylase (AAG/MPG) and four 
bifunctional: 8-oxoguanina-DNA glycosylase (OGG1), E. coli endonuclease III homo-
log (NTH1) endonuclease VIII-like glycosylase 1 and 2 (NEIL1 and 2) [38–41]. After 
the action of glycosylases, the next step, DNA end processing, is catalyzed by nuclear 
BER enzymes that are also found in mitochondria, as apurinic-apyrimidinic endo-
nuclease 1 (APE1) and polynucleotide kinase-3′-phosphatase (PNKP) [35], further the 
Figure 1. 
Mitochondrial import and mtDNA repair pathways. The elements that participate in mitochondrial genome 
maintenance are nuclear encoded; therefore, mitochondria need to import these effector proteins, which are 
involved in different repair pathways.
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synthesis is carried out by the main mitochondrial polymerase (Polγ). It was recently 
reported that polymerase beta (Polβ) also localizes within mitochondria, whereas 
similar to the nucleus, it has a relevant role in mtDNA maintenance and mitochondrial 
homeostasis through its participation in BER [42]. It has also been observed that FEN1, 
DNA2, and EXOG are involved in the removal of DNA flap generated by polymerase 
strand displacement synthesis [43]. Finally, the ligation activity is made by mitochon-
drial ligase III [44]. In conclusion, despite that BER is the most characterized pathway 
in mitochondria, it is still unknown whether all the nuclear elements are conserved in 
mitochondrial BER, or on the contrary, if this pathway have specific proteins that do 
not participate in nuclear version of BER, it is not well understood either which are the 
regulatory signals that controls the import of these elements to mitochondria.
4.2 Nucleotide excision repair (NER)
Nucleotide excision repair (NER) pathway is a complex machinery involved in 
recognition of lesions, adducts or structures that modifies the DNA double helix 
structure, having the possibility of blocking transcription, replication, and thus 
affecting DNA stability. One of the most important features of NER is its versatility 
on a wide kind of lesions since they are detected and repaired. Roughly, the process 
starts with damage recognition, next, the damaged strand is cleaved at both sides 
of the lesion to be removed later, then the missing sequence is synthesized using the 
complementary strand as a template, and finally the ends are ligated, thus restoring 
DNA sequence and integrity [45].
There is a large body of evidence reporting the absence of nucleotide excision 
repair activity in mitochondria. The first observation about this lack was made by 
Clayton et al. in 1974 [2], who reported that mitochondria were unable to remove 
UV-induced pyrimidine dimers. As a result, lesions that are normally repaired in 
nucleus by NER could persist in mitochondrial genome; this damage is not only 
restricted to photodimers, since NER also participates in repair of other bulky 
lesions and a subset of oxidative DNA damage [1]. In the nucleus, bulky lesions 
can also be overcome through the use of specialized translesion synthesis (TLS) 
polymerases; however, in mitochondria, the major polymerase (Polγ) presents 
a weakly thymine dimer bypass activity in vitro and at present, it is unknown 
whether this activity is conserved in vivo [46]. On the other hand, it was recently 
reported that polymerase theta (Polθ), an enzyme that acts as a translesion bypass 
polymerase, thus promoting the pass of replicative stalling lesions in the nucleus 
[47], is localized to mitochondria. Additionally, it was observed that there is 
an increase of Polθ localization to mitochondria after treating the cells with an 
oxidative agent, suggesting that the enzyme is recruited to the organelle when this 
kind of damage is inflicted, where it could facilitate translesion bypass synthesis. 
Interestingly, in POLQ KO cells, the rate of point mutation in mtDNA was signifi-
cantly reduced after oxidative treatment; this observation indicates that Polθ is 
involved in a pathway of error-prone DNA synthesis that may facilitate replication 
in mitochondria [48].
Despite that the nucleotide excision repair pathway has not been clearly recog-
nized in mitochondria, there are several proteins involved in the nuclear version of 
this pathway that not only localize to the organelle but also they accumulate upon 
oxidative damage, and when they are depleted from cells, the number of point muta-
tion is increased, observations that strongly suggest their participation in mtDNA 
maintenance. Some of these proteins are: Cockayne syndrome A (CSA), Cockayne 
syndrome B (CSB), and Rad23A [48–50]. Therefore, further investigation is needed 
to completely rule out NER pathway from mitochondria, or to elucidate whether 
these mentioned proteins are involved in other pathways different to nucleus.
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4.3 Mismatch repair (MMR)
MMR is a highly conserved pathway involved in the correction of misincorpora-
tion and slippage mistakes committed by polymerases during DNA replication, and 
base mismatches generated by base deamination, alkylation, and oxidation [3]. In 
general terms, MMR process presents the next steps: localization of the mismatch 
and identification of the newly synthesized strand, excision at both extremes of the 
mismatch lesion, DNA resynthesis, and finally ligation to complete the process [10].
The first demonstration of mammalian mitochondria capable to repair mismatch 
lesions was done by Mason et al. [51]. They observed that rat liver mitochondrial 
lysates repaired G-T and G-G mismatches; however, by using immunodetection no 
MSH2, a key nuclear element in MMR, was detected in these lysates, suggesting 
that mitochondrial MMR activity uses different elements to those of the nucleus. 
Posteriorly, in the pursuit of proteins responsible for the activity observed, one study 
reported that mismatches and small IDLs in mitochondrial genome are recognized 
by the Y-box binding protein 1 (YB1), which also localizes to nucleus where it exerts 
other functions, and its depletion in cultured cells triggers an increased mutagenesis 
in mtDNA. In addition, it was demonstrated that MMR activity is independent of 
MSH2 and that MSH3, MSH6 or MLH1 are not present in human mitochondria, at 
least under the experimental conditions employed [52]. In contrast to the previous 
observation, it was later demonstrated that MLH1 do localizes to mitochondria 
[53]. Through overexpression of Mlh1 or Msh2 in retinal endothelial cells, it was 
determined that MLH1 has a protective role in mtDNA after glucose-induced DNA 
damage, and on the other hand, this protective effect was not detected when Msh2 
was overexpressed, observation that suggests no participation in mtDNA mainte-
nance [54], in accordance with previous studies. Additionally, it was reported that 
the incidence of base-mismatches in mtDNA in diabetic retina is a consequence of 
expression silencing of MLH1 by methylation of its promoter, activity performed by 
Dnmt1, enzyme overexpressed in diabetes. Thus, these observations propose that 
MLH1 has an important role in mtDNA maintenance, since its silencing by methyla-
tion triggers mtDNA damage [55]. In summary, MMR pathway is involved in mito-
chondrial genome maintenance; however, not all the elements implicated have been 
found. It could be possible that the proteins of mitochondrial MMR may have a dif-
ferent splicing or post translational versions than nuclear ones, which impairs their 
identification through antibody-based techniques, or in the other hand, mitochon-
drial MMR could not depend of all the elements involved in the canonical nuclear 
form, as it was seen with the participation of YB1 [52]. In any case, more research is 
needed to find more MMR nuclear factors within mitochondria or to discover new 
ones and be able to catalog the mitochondrial MMR as an original pathway.
4.4 Single strand break repair (SSBR)
The repair of SSBs in mitochondria is achieved through a BER subpathway 
known as base excision/SSB repair (which is also present in nucleus), since both 
mechanisms share common component, especially in the last steps: gap filling and 
DNA ligation [10, 24]. Indeed, most of the SSBs can be repaired by elements of BER 
pathway: APE1, PKPK, and Polγ [24]. Other members of mitochondrial SSB repair 
include: PARP1, a protein implicated in the detection of SSBs in the nucleus and also 
more recently observed in mitochondria, where not only it binds to mtDNA, but 
also when is depleted, this provokes accumulations of DNA damage, thus confirm-
ing its participation in mtDNA maintenance [56]. Besides, the participation of 
ExoG in SSB repair has been elucidated, since its depletion induces mitochondrial 
persisting SSBs that eventually lead to apoptosis [57].
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As was previously mentioned, there are some lesions associated to SSB, like trapped 
topoisomerase 1 (Top1), damage that can be repaired through the action of tyrosil-
DNA phosphodiesterase 1 (TDP1), an important enzyme involved in the release of 
covalently trapped Top1 with DNA that was first described in yeast [58]. In addition 
to its well characterized function, it has been observed that TDP1 also removes other 
types of 3′-blocking lesions, resulting oxidative damage [59–61]. A fraction of TDP1 
(nuclear encoded) localizes to the mitochondria, where it has been implicated in 
mtDNA repair, since the treatment with chain terminator nucleotide analogs (CTNAs), 
which are also substrates of this enzyme, in tdp1−/− cells generate a reduction in mtDNA 
copy number, whereas wild type cells remain unaffected [61, 62]. These findings 
confirm the involvement of TDP1 in mtDNA damage repair, in this case induced by 
CTNAs. Another SSB-related lesion is the generation of a covalent binding of adenine 
monophosphate (AMP) to the 5′end of mtDNA, and this error is promoted by abortive 
ligase activity. The resolution of such damage relies in aprataxin (APTX) protein that 
is able to remove 5′-adenylate groups. APTX localizes to mitochondria, whereas its 
depletion generates a decline of mtDNA copy number as well as higher levels of DNA 
damage, observations that suggest a direct role of this enzyme in mtDNA maintenance 
[63]. If any of the lesions mentioned remains unrepaired, further complications may 
appear, since SSBs may progress to DSBs, which are more deleterious to cells.
4.5 Double strand break repair (DSBR)
In general, cells of higher eukaryotes use two main approaches to repair DSBs. 
The first approach is through the union of the ends in a nonhomologous dependent 
way, this pathway is termed nonhomologous end joining (NHEJ); it has been 
determined that NHEJ possesses some alternatives versions that use noncanoni-
cal elements, these sub pathways are known as alternative NHEJ (A-NHEJ); the 
repair with these mechanisms guarantee the restoration of DNA integrity but not 
sequence.
4.5.1 Nonhomologous end joining (NHEJ)
Nonhomologous end joining (NHEJ) is one of the two main pathways used by 
the cells to repair DNA double strand breaks. Similar to most DNA repair processes, 
NHEJ is based on three general steps: the action of a nuclease to resect the damaged 
DNA, next, the fill-in to make new DNA by a polymerase, and finally the participa-
tion of a ligase to restore the integrity of the strands. One of the most interesting 
features of NHEJ is the diversity of substrates that can use and convert to joined 
products [64]. By virtue of its template-independent operation, NHEJ is associated 
with insertions and deletions and hence with a lack of reliable restoration [26].
It has been observed that mammalian mitochondria do possess the capacity 
to bind DNA ends, activity that is retained even in Ku-deficient cells [65], addi-
tionally, the efficiency and precision of this activity apparently depend on the 
structure of the ends generated, since blunt-ended DNA fragment repaired are 
less conserved than sticky ends in comparison to the original [66]. Tadi et al. [67] 
demonstrated that mitochondria have a noncanonical version of NHEJ, also named 
alternative NHEJ (A-NHEJ). The repair by this pathway is based on microhomol-
ogy and is sometimes associated with long deletions, and hence it is described as 
microhomology-mediated end joining (MMEJ). In this same study, using rodents 
and human mitochondrial extracts, a lack of end-to-end joining of nonligatable 
broken DNA was observed, the fact that suggests the absence of a functionally 
operative canonical NHEJ in mitochondria, or at least is undetected with the tech-
niques used. In contrast, mitochondria have the ability to join oligomeric dsDNAs 
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harboring direct repeats (microhomology) that vary in length, from 5 to 22 nt, with 
an efficiency that is enhanced with the increase in the length of homology. These 
results are supported by a previous observation, where DSBs are induced in mice 
through mitochondrially targeted restriction endonuclease (Pst I), and the repaired 
mtDNA presented small directed repeats (a few nucleotides) at the breakpoint [68], 
resolution that fits with the repair manner of MMEJ, and in addition, these repair 
products have also been observed in most of the mtDNA deletions associated with 
human diseases, which are mostly (~85%) flanked by small direct repeats [69]. 
Besides, it has been determined that this mitochondrial MMEJ activity involved the 
proteins CtIP, FEN1, Mre11, PARP1, and ligase III [67].
Therefore, MMEJ has been proposed as a central pathway in the repair of double 
strand breaks and maintenance of mammalian mitochondrial genome, and the use 
of this pathway and possibly not C-NHEJ may explain the Ku independence pro-
teins to exert the joining activity as was previously mentioned. The possible absence 
of C-NHEJ activity in mitochondria is contrasting with the observation that anti-
bodies to KU70 and KU80 cross-react with proteins from mitochondrial extracts 
with DNA end-binding activity [10, 70]. Furthermore, it has been determined that 
XRCC4, a mediator protein of nuclear DSB repair pathway, is present in mitochon-
drial, where it is indeed involved in mtDNA repair and possibly associated with 
DNA ligase III [48]. In summary, at present no NHEJ activity has been described in 
mitochondria; however, this organelle presents the ability to join broken DNA ends, 
and it appears that this action depends on the structure of the ends generated and in 
the presence of homology at both ends of the DSB, further, the repair by MMEJ may 
explain the deletions observed in the majority of mitochondrial diseases.
4.5.2 Homologous recombination (HR)
Homologous recombination (HR) is a ubiquitous process conserved from 
bacteriophages to humans and is one of the most important pathways used by the 
cells to deal with DNA double strand breaks. To achieve the restoration of molecular 
integrity and sequence in a free-error manner, HR needs a homologous sequence to 
use it as a template [26, 71].
It has been determined that HR is essential for preservation of mtDNA in plants, 
yeast, and fungi, and on the other hand, although there is evidence about HR in 
mammalian, its significance in vivo is not clear [1]. One of the first reports about 
mitochondrial homologous repair capabilities was made by Thyagarajan et al. [72] 
where they observed that mitochondrial protein extracts from mammalian cells 
catalyzed homologous recombination repair of plasmid DNA substrates, therefore 
concluding that mitochondria do possess the machinery to perform this process. 
Additionally, after preincubating protein extracts with anti-RecA antibodies, an 
inhibition of the reaction was observed, fact that suggests the participation of a 
mammalian mitochondrial RecA homolog. Supporting this evidence, in 2010, Sage 
et al. [73] demonstrated that Rad51 and the related proteins, Rad51C and XRCC3, 
localize to human mitochondria, and they also reported that the protein levels were 
enriched after stress induction and that depletion of any of these elements generates 
a dramatic decrease in mtDNA copy number, these results strongly suggest some 
type of HR participation in mitochondrial genome maintenance. Other proteins 
involved in HR have been observed in mitochondria, and their participation in 
mtDNA repair has been validated, such as Dna2 [74] and Mre11 [67, 75, 76]; more-
over, it has been suggested that ExoG could supply Exo1, and therefore, many of the 
factors needed to perform HR process are present in mitochondria.
Recently, using biochemical assays, it was determined that HR is the major 
DSBR mechanism, where it has a role in maintenance of mitochondrial genome 
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integrity, since the induction of DSBs significantly enhanced this process. Besides 
the participation of Rad51, Mre11 and Nibrin relevance in HR was confirmed by 
suppression of HR-mediated repair after immunodepletion of these proteins in 
the mitochondrial extracts [76]. The process of mitochondrial HR may proceed in 
two ways, one through intramolecular recombinant events, where a sole mtDNA 
molecule recombines with itself, and a second form, where a molecule can recom-
bine with another one homologous or heterologous [77, 78]. Despite the knowledge 
of the elements involved in mitochondrial HR have increased over the last years, the 
exact mechanism about how HR is achieved in mitochondria is lacking in compari-
son to the nuclear models [33].
The second approach is through the use of nondamaged homologous sequences; 
this kind of repair restores molecular integrity as well as sequence; another path-
way that uses homology sequences is single strand annealing (SSA), which needs 
directed repeats in both ends of the DSB, in such a way that when repairing, it 
restores integrity and sequence but at the expense of a variable length deletion [26].
4.6 Other pathways
As it has been previously described in this chapter, mitochondria have a repertoire 
of elements to deal with DNA damage, even it has been observed that mitochondria 
possess a mechanism to “prevent” further lesions (described below). However, if the 
mtDNA lesions surpass the mitochondrial repair capabilities, the cell maintains other 
options to avoid a higher damage, and in these circumstances, it is possible to degrade 
the unrepairable mtDNA, the organelle or even the whole cell [10].
4.6.1 Sanitation of the dNTP pool
The DNA is not the only molecule susceptible to chemical damage, the deoxy-
ribonucleotide triphosphates (dNTPs) pool is also affected, being oxidative dam-
age one of the most recurrent alterations [79]. If unrepaired, these lesions could 
become a source of mismatch errors during DNA synthesis [3]. To cope with this 
threat, mitochondria have MTH1, an specialized enzyme also found in the nucleus, 
which can hydrolyze oxidized dNTPs such as 8-oxo-20-deoxyguanosine triphos-
phate (8-oxo-dGTP), 8-oxo-20-deoxyadenosine triphosphate (8-oxo-dATP), and 
2-hydroxy-20-deoxtadenosine triphosphate (2-hydroxy-ATP) to corresponding 
monophosphates, which cannot be assembled in the DNA by polymerases [41, 80]. 
In 2008, Pursell et al. [81] reported that 8-oxo-dGTP exists in some rat tissues at 
levels that are potentially mutagenic; therefore, these data suggest that oxidized 
dNTP precursors could generate mutagenesis in vivo and consequently promote 
mitochondrial dysfunction. In addition, it was reported that a pathogenic variant of 
Polγ, which is present in patients with progressive external ophthalmoplegia (PEO), 
increases 8-oxo-dGTP misincorporation, observation that establishes a relationship 
between the oxidative lesions and increased mtDNA damage observed in other mod-
els with this pathogenic version, and misincorporation of oxidized nucleotides [82]. 
In summary, although sanitation of premutagenic free nucleotides is not properly a 
DNA repair mechanism, its participation prevents the formation of mismatches in 
mitochondrial genome and therefore reduces the probability of mutagenesis.
4.6.2 mtDNA degradation
Compared to nuclear genome, mitochondrial genomic material has a remark-
able advantage about DNA damage and repair, its redundancy, consisting of 
hundreds to thousands of copies per cell. Due to this characteristic, mitochondria 
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can dispose of a considerable fraction of mtDNA, where its repair capabilities 
were exceeded; however, it does not compromise organelle functions, and this 
is not an option for nucleus, where the diploid genome cannot be submitted to 
degradation without affecting the cellular homeostasis [3]. It is thought that after 
mtDNA degradation, the lost molecules are restored by mitochondrial genome 
turnover, a process that was first described several decades ago [83] (Figure 2). 
There is a wide body of evidence that supports this hypothesis of mtDNA deg-
radation after unrepairable insults; for instance, it was observed that when one 
of the initial steps of the BER repair pathway is inhibited by methoxyamine 
drug, the increase of incidence of oxidative and alkylating damage enhanced 
the mtDNA degradation [84]; additionally, through qPCR analysis, it has been 
shown a mtDNA amount decrease after persisting exposure with the oxidizing 
agent hydrogen peroxide [85, 86]. Furthermore, the absence of mutation fixation 
after persisting cell treatment with alkylating agents which have a high mutagenic 
potential suggests that due to the lack of mechanisms for repairing bulky lesion, 
the mtDNA could be selectively degraded and to prevent further modifications 
[87]. Nowadays, it is not completely clear how the mitochondrion degrades its 
damaged DNA; however, it has been recently determined that endonuclease G 
(EndoG) has an important role in mtDNA depletion, since it promotes cleavage of 
mtDNA as a response to oxidative and nitrosative stress, action that subsequently 
generates an upregulation of mtDNA replication as an indirect outcome [88]. This 
evidence is supported by the fact that endo G is the most abundant and active 
nuclease within mitochondria, and it has a preference on oxidized DNA harboring 
single-strand breaks or distorted DNA product of crosslinking agents to exert its 
endonuclease activity in vitro [89], also it has been reported that this nuclease 
preferentially cleaves 5-hydroxymethylcytosine an oxidized product of 5-methyl-
cytosine [90]. In conclusion, despite that additional research is needed to eluci-
date the whole mechanisms and elements that participate in mtDNA degradation, 
this pathway emerges as a unique and mitochondrial specific method to maintain 
DNA integrity.
Figure 2. 
mtDNA degradation and mitophagy. (A) Damaged mtDNA (yellow circles) can be selectively degraded 
inside mitochondria, thus keeping “healthy” mtDNA (green circles), then this can replicate to re-establish 
mitochondrial genome homeostasis. (B) If the mtDNA is severely damaged and the repair mechanism is 
surpassed, injured mitochondria can be selectively degraded by the formation of an autophagosome and 
subsequent fusion with lysosomes [91]. On the other hand, the mtDNA lesions can also trigger cell apoptosis.
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4.6.3 Mitochondrial clearance, dynamics, and apoptosis
In general terms, autophagy is a highly conserved degradative mechanism 
used by cells to maintain homeostasis [92]. This is a finely regulated process that 
takes part in cell growth, development, and in the maintenance of an equilibrium 
between synthesis, degradation and recycling of cellular elements including 
whole organelles [11]. There is a specialized sub pathway of autophagy, which is 
specifically involved in degradation of damaged and dysfunctional mitochon-
dria, and this procedure is known as mitophagy or mitochondrial clearance. 
Although mitophagy can emerge as a programmed cellular event, like the one 
that is observed during erythroblast maturation in order to generate mature red 
blood cells lacking mitochondria [11], it has been proposed that mitophagy could 
participate in the elimination of organelles harboring low levels of DNA damage 
stress. On the other hand, when the DNA lesions are too many to handle with 
mtDNA repair mechanism or by mitochondrial clearance, the cellular response 
could trigger apoptosis [93], therefore the choice of which pathway must be used 
depends on the degree of DNA damage (Figure 2). In accordance with the previ-
ous mechanism, Suen et al. [94] observed selectively degradation by mitophagy of 
organelles harboring deleterious COXI mutations after overexpressing the protein 
Parkin, which translocated to affected mitochondria and induced autophagic 
elimination, thus this selection enriched cells for nonmutated mtDNA and restor-
ing cytochrome c oxidase activity [95].
It appears that mitophagy is closely associated with mitochondrial dynamics 
processes: fission and fusion [96]. Fusion is the joining of two organelles to form 
one, this mechanism allows mitochondria to distribute mtDNA and to replenish it 
when is damaged, therefore safeguarding mtDNA integrity and protecting it from 
mutations [97]. On the other hand, fission is the division of a single organelle to 
create two, this process is very important to cellular viability, it contributes to sym-
metrical distribution of mitochondria during mitosis, and promotes the removal 
of lesioned organelles by partitioning the damaged elements (like mtDNA) to a 
derived mitochondria that can fuse to a healthy one with the intention of recovering 
functionality or to be degraded by mitophagy. Therefore, mitochondrial removal 
by mitophagy is preceded by mitochondrial fission, which is capable of dividing 
the organelle into smaller pieces to be degraded easily [98]. When mitochondrial 
clearance, fusion, or fission are dysfunctional, the cells could be severely affected, 
since it has been observed that in these situations, an increase in mtDNA instability 
and generation of neurodegenerative, cardiovascular, and age-related diseases were 
obtained [99].
5. mtDNA repair, diseases, and aging
Mitochondrial diseases are a heterogeneous group of illnesses affecting multiple 
organs and leading to eventual degeneration and in some cases premature death. 
These affectations have origin in mutations on mtDNA, which are generated by 
errors during DNA replication, exogenous sources, and ROS; however, mitochon-
drial dysfunction may also arise from mutations in nuclear genes which encode 
proteins with mitochondrial function, involved in several processes like biogenesis, 
transcription, replication, mitochondrial dynamics, and mtDNA repair, among 
others. Of interest, neurodegeneration is a prevalent trait in mitochondrial diseases, 
maybe because the brain needs a higher demand of energy in comparison with other 
tissues [11]. On the other hand, there is a large body of evidence that underscores 
the relationship between mitochondrial disorders and aging; however, there is still 
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controversy about whether these mutations in the mtDNA are the product of age-
related disorders or they are themselves the cause [100].
About the genes involved in mtDNA maintenance, it has been well established 
that failure of the mtDNA repair pathways may promote diseases and age-related 
disorders in humans [11, 28]; in addition to mutations, the reduction of mtDNA 
copy number has also been associated with neurodegeneration, aging, diabetes, and 
cancer [101]. For example, it has been observed that the lack of proofreading activ-
ity of Polγ in mice generates multi-systemic disease and phenotypes resembling to 
premature aging [102], furthermore, over 200 mutations in POLG have been associ-
ated with mitochondrial diseases, these POLG-related disorders can be classified 
into five main phenotypes of neurodegeneration: Alpers-Huttenlocher syndrome 
(AHS), childhood myocerebrohepatopathy spectrum (MCHS), myoclonic epilepsy 
myopathy sensory ataxia (MEMSA), ataxia neuropathy spectrum (ANS), and PEO 
[28], besides, mutations in Twinkle helicase often causes infantile onset spino-
cerebellar ataxia (IOSCA), which usually appears in early childhood [103]. Other 
mtDNA repair elements, such as APTX and TDP1, implicated in SSBR, are related 
with the generation of ataxia with ocular motor apraxia (AOA1) when are mutated 
[10, 104]. Also, defects in the proteins CSA and CSB, implicated in the possibly 
mitochondrial DNA repair transcription coupled-NER pathway, are related with the 
development of progressive cerebellar pathology [105]. Furthermore, alterations in 
fusion, fission, or mitophagy processes due to mutations in the proteins involved 
generate mtDNA instability, which in turn may induce neurodegenerative, cardio-
vascular, and age-related diseases [99], such is the case of MFN2, which is impli-
cated in mitochondria fusion, and its alteration lead to organelle fragmentation 
and causes axonal Charcot-Marie-Tooth disease (CMT2A) [106], also mutations 
in OPA1, lead to optic atrophy, affectation that can be accompanied with hearing 
loss and ophthalmoplegia [107]. Additionally, mutations in DNA2 and mitochon-
drial genome maintenance exonuclease 1 (MGME1) nucleases are implicated in 
ophthalmoplegia, myopathy, and mtDNA depletion [108, 109]. In conclusion, the 
importance of mtDNA maintenance lies in the observation that when the repair 
elements are affected, or the mechanisms exceeded, the risk of disease development 
increases, thus the understanding of these alterations may shed light for clinical 
targets to prevent diseases or treat them.
6. Concluding remarks
After decades of study, it has been concluded that like nucleus, mitochondria 
do possess specific mechanisms to maintain integrity of its small and polyploid 
genome, and although nowadays, the complete repertoire of elements participating 
in mtDNA repair has not been identified, it appears that these pathways resemble 
those of nucleus but operating with fewer elements. In addition, mitochondria have 
evolved organelle specific mechanisms which work as a backup when the repair 
pathways are surpassed by the amount of damage and that would be impossible to 
carry out in nuclear genome. In conclusion, the repair of mitochondrial genome is a 
field in continuous growth that promises new discoveries in the years to come.
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